par Nortier, Joëlle ;Muniz Martinez, Marie Carmen;Schmeiser, H.-H.;Arlt, V.-M.;Bieler, C.-A.;Petein, Michel ;Depierreux, Michel ;De Pauw, Luc ;Abramowicz, Daniel ;Vereerstraeten, Pierre ;Vanherweghem, Jean-Louis
Référence The New England journal of medicine, 342, 23, page (1686-92)
Publication Publié, 2000
Référence The New England journal of medicine, 342, 23, page (1686-92)
Publication Publié, 2000
Article révisé par les pairs
Titre: |
|
Auteur: | Nortier, Joëlle; Muniz Martinez, Marie Carmen; Schmeiser, H.-H.; Arlt, V.-M.; Bieler, C.-A.; Petein, Michel; Depierreux, Michel; De Pauw, Luc; Abramowicz, Daniel; Vereerstraeten, Pierre; Vanherweghem, Jean-Louis |
Informations sur la publication: | The New England journal of medicine, 342, 23, page (1686-92) |
Statut de publication: | Publié, 2000 |
Sujet CREF: | Cancérologie |
Néphrologie - urologie | |
Autres spécialisations médicales et paramédicales | |
Homéopathie | |
MeSH keywords: | Anti-Obesity Agents -- adverse effects |
Aristolochic Acids | |
Carcinogens -- adverse effects | |
Carcinogens -- analysis | |
Carcinogens -- metabolism | |
DNA Adducts -- analysis | |
Dose-Response Relationship, Drug | |
Drugs, Chinese Herbal -- adverse effects | |
Female | |
Humans | |
Kidney -- pathology | |
Kidney Failure, Chronic -- chemically induced | |
Kidney Failure, Chronic -- pathology | |
Kidney Failure, Chronic -- therapy | |
Male | |
Middle Aged | |
Ochratoxins -- analysis | |
Phenanthrenes -- adverse effects | |
Phenanthrenes -- analysis | |
Phenanthrenes -- metabolism | |
Prevalence | |
Risk Factors | |
Ureter -- pathology | |
Urologic Neoplasms -- chemically induced | |
Urologic Neoplasms -- pathology | |
Urothelium -- pathology | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0028-4793 |
info:doi/10.1056/NEJM200006083422301 | |
info:scp/0034622082 | |
info:pmid/10841870 | |
jlv-0115 |